Pharsight

Drugs that contain Alendronate Sodium

1. Binosto patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7964212 RADIUS Effervescent compositions comprising phosphonates and methods related thereto
Mar, 2023

(1 year, 3 months ago)

US7488496 RADIUS Effervescent compositions comprising bisphosphonates and methods related thereto
Aug, 2023

(10 months ago)

US9592195 RADIUS Stable effervescent bisphosphonate formulations with rapid solubilization characteristics
Dec, 2031

(7 years from now)

Market Authorisation Date: 12 March, 2012

Treatment: NA

Dosage: TABLET, EFFERVESCENT;ORAL

More Information on Dosage

BINOSTO family patents

Family Patents

2. Fosamax patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6090410 ORGANON Dry mix formulation for bisphosphonic acids
Dec, 2012

(11 years ago)

US6194004 ORGANON Dry mix formulation for bisphosphonic acids
Dec, 2012

(11 years ago)

US5681590 ORGANON Dry mix formulation for bisphosphonic acids
Dec, 2012

(11 years ago)

US5358941 ORGANON Dry mix formulation for bisphosphonic acids with lactose
Dec, 2012

(11 years ago)

US5681590

(Pediatric)

ORGANON Dry mix formulation for bisphosphonic acids
Jun, 2013

(11 years ago)

US5358941

(Pediatric)

ORGANON Dry mix formulation for bisphosphonic acids with lactose
Jun, 2013

(11 years ago)

US6090410

(Pediatric)

ORGANON Dry mix formulation for bisphosphonic acids
Jun, 2013

(11 years ago)

US6194004

(Pediatric)

ORGANON Dry mix formulation for bisphosphonic acids
Jun, 2013

(11 years ago)

Market Authorisation Date: 25 April, 1997

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of FOSAMAX before it's drug patent expiration?
More Information on Dosage

FOSAMAX family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Fosamax patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5462932 MERCK Oral liquid alendronate formulations
May, 2014

(10 years ago)

US5462932

(Pediatric)

MERCK Oral liquid alendronate formulations
Nov, 2014

(9 years ago)

US6015801 MERCK Method for inhibiting bone resorption
Jul, 2018

(5 years ago)

US6225294 MERCK Method for inhibiting bone resorption
Jul, 2018

(5 years ago)

US5994329 MERCK Method for inhibiting bone resorption
Jul, 2018

(5 years ago)

US6225294

(Pediatric)

MERCK Method for inhibiting bone resorption
Jan, 2019

(5 years ago)

US6015801

(Pediatric)

MERCK Method for inhibiting bone resorption
Jan, 2019

(5 years ago)

US5994329

(Pediatric)

MERCK Method for inhibiting bone resorption
Jan, 2019

(5 years ago)

Market Authorisation Date: 17 September, 2003

Treatment: NA

Dosage: SOLUTION;ORAL

How can I launch a generic of FOSAMAX before it's drug patent expiration?
More Information on Dosage

FOSAMAX family patents

Family Patents